Location History:
- Glasgow, GB (2013 - 2023)
- Scotland, GB (2024)
Company Filing History:
6 out of 149 
1 out of 3,540 
Years Active: 2013-2024
Title: Michelle Maclean: Innovator in Pathogen Inactivation Technologies
Introduction
Michelle Maclean is a prominent inventor based in Glasgow, GB. She has made significant contributions to the field of medical technology, particularly in the area of pathogen inactivation in blood products. With a total of 6 patents to her name, her work has the potential to enhance the safety of blood transfusions and improve patient outcomes.
Latest Patents
One of her latest patents focuses on the inactivation of pathogens in ex vivo blood products stored in bags using visible light. This innovative method involves directing visible light radiation from an illuminating device into blood product storage containers. The goal is to achieve effective pathogen inactivation without the need for added photosensitizing agents. The apparatus includes a control unit that operates a light source emitting light in the wavelength range of about 380-500 nm. This light penetrates the bag material and the opaque blood product to inactivate pathogens while ensuring that the blood product remains undamaged.
Another notable patent addresses the inactivation of medically important Gram-positive bacteria, including Methicillin-resistant Staphylococcus aureus (MRSA) and Coagulase-Negative Staphylococci (CONS). This method also utilizes visible light exposure, specifically within the wavelength range of 400-500 nm, to effectively target and inactivate these harmful bacteria.
Career Highlights
Michelle has worked with esteemed institutions such as the University of Strathclyde and the National Institutes of Health, a component of the US Department of Health & Human Services. Her experience in these organizations has allowed her to develop and refine her innovative technologies, contributing to advancements in medical safety.
Collaborations
Throughout her career, Michelle has collaborated with notable colleagues, including John Galloway Anderson and Scott John MacGregor. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking technologies.
Conclusion
Michelle Maclean is a trailblazer in the field of pathogen inactivation technologies, with her innovative patents paving the way for safer medical practices. Her contributions to the industry highlight the importance of research and development in enhancing patient care.